Filing Details
- Accession Number:
- 0001628656-19-000005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-02 16:40:42
- Reporting Period:
- 2019-08-01
- Accepted Time:
- 2019-08-02 16:40:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899923 | Myriad Genetics Inc | MYGN | In Vitro & In Vivo Diagnostic Substances (2835) | 870494517 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1628656 | Bernard Tobin | 320 Wakara Way Salt Lake City UT 84108 | President Crescendo Bioscience | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-08-01 | 11,712 | $40.00 | 146,040 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
